 |
인쇄하기
취소
|
NKBio files patent application for new atherosclerosis treatment
NKBio says it has filed its domestic patent application for cytokeratin-1 compound, a potential drug candidate in the prevention and treatment of atherosclerosis.
The company notes that cytokeratin-1, which is associated with atherosclerosis in the body, will pave the way to clarify the etiology of vascular diseases, a company official says.
Atherosclerosis or “hardening of the arteries"...
The company notes that cytokeratin-1, which is associated with atherosclerosis in the body, will pave the way to clarify the etiology of vascular diseases, a company official says.
Atherosclerosis or “hardening of the arteries"...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.